Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
2 hedge funds and large institutions have $5.29K invested in Bio-Path Holdings Inc in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.
90% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 21
91% less funds holding
Funds holding: 22 → 2 (-20)
99% less capital invested
Capital invested by funds: $370K → $5.29K (-$365K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$25.7K |
| 2 |
Jones Financial Companies
Des Peres,
Missouri
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$276K |
| 2 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
-$17.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.7K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$14.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$14.2K |
BPTH Hedge Fund Activity: Q1 2025 in Review
2 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2025, worth a combined $5.29K — down 99% from $370K a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of BPTH and 2 opened new positions — a net loss of 19 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was XTX Topco, opening a new position worth an estimated $25.7K. The largest seller was Armistice Capital, exiting entirely with an estimated $276K sold.
- 2 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2025, down from 22 in Q4 2024.
- Funds reported $5.29K of Bio-Path Holdings Inc stock for Q1 2025, down 99% quarter-over-quarter.
- 2 funds opened new Bio-Path Holdings Inc positions in Q1 2025 and 21 closed out, a net change of -19 holders.
- The largest Bio-Path Holdings Inc buyer in Q1 2025 was XTX Topco, an estimated $25.7K added.
- The largest Bio-Path Holdings Inc seller in Q1 2025 was Armistice Capital, an estimated $276K sold.
Based on aggregated 13F filings for Q1 2025.